167 related articles for article (PubMed ID: 17364956)
1. Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome.
Vibo R; Kõrv J; Roose M; Kampus P; Muda P; Zilmer K; Zilmer M
Free Radic Res; 2007 Mar; 41(3):282-7. PubMed ID: 17364956
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study.
Shin DH; Lee PH; Bang OY
Arch Neurol; 2005 Aug; 62(8):1232-7. PubMed ID: 16087764
[TBL] [Abstract][Full Text] [Related]
3. The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke.
Guldiken B; Guldiken S; Turgut B; Turgut N; Demir M; Celik Y; Arikan E; Tugrul A
Angiology; 2008; 59(2):224-9. PubMed ID: 18388043
[TBL] [Abstract][Full Text] [Related]
4. Use of magnetic resonance angiography to predict long-term outcomes of ischemic stroke patients with concurrent stenoses in Hong Kong.
Man BL; Fu YP; Chan YY; Lam W; Hui CF; Leung WH; Wong KS
Cerebrovasc Dis; 2009; 28(2):112-8. PubMed ID: 19506369
[TBL] [Abstract][Full Text] [Related]
5. Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke.
Park JH; Kwon HM
Clin Neurol Neurosurg; 2008 Mar; 110(3):215-21. PubMed ID: 18055103
[TBL] [Abstract][Full Text] [Related]
6. Association of serum lipid indices with large artery atherosclerotic stroke.
Bang OY; Saver JL; Liebeskind DS; Pineda S; Ovbiagele B
Neurology; 2008 Mar; 70(11):841-7. PubMed ID: 18160673
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory markers and conventional atherosclerotic risk factors in acute ischemic stroke: comparative study between vascular disease subtypes.
Suwanwela NC; Chutinet A; Phanthumchinda K
J Med Assoc Thai; 2006 Dec; 89(12):2021-7. PubMed ID: 17214052
[TBL] [Abstract][Full Text] [Related]
8. Ischemic stroke subtypes: risk factors, functional outcome and recurrence.
Murat Sumer M; Erturk O
Neurol Sci; 2002 Mar; 22(6):449-54. PubMed ID: 11976976
[TBL] [Abstract][Full Text] [Related]
9. Study of some markers of inflammation in atherothrombotic pathogenesis of acute ischemic stroke.
Cojocaru IM; Cojocaru M; Muşuroi C; Druţă A; Băcanu M
Rom J Intern Med; 2002; 40(1-4):103-16. PubMed ID: 15526546
[TBL] [Abstract][Full Text] [Related]
10. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
11. Early recurrent ischemic lesions on diffusion-weighted imaging in symptomatic intracranial atherosclerosis.
Kang DW; Kwon SU; Yoo SH; Kwon KY; Choi CG; Kim SJ; Koh JY; Kim JS
Arch Neurol; 2007 Jan; 64(1):50-4. PubMed ID: 17210808
[TBL] [Abstract][Full Text] [Related]
12. Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function.
Xue J; Dong Q; Han X; You H; Gu Y; Lin S
Ther Apher Dial; 2007 Jun; 11(3):171-6. PubMed ID: 17497997
[TBL] [Abstract][Full Text] [Related]
13. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke.
Licata G; Tuttolomondo A; Di Raimondo D; Corrao S; Di Sciacca R; Pinto A
Thromb Haemost; 2009 May; 101(5):929-37. PubMed ID: 19404547
[TBL] [Abstract][Full Text] [Related]
14. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome.
Tuttolomondo A; Pinto A; Salemi G; Di Raimondo D; Di Sciacca R; Fernandez P; Ragonese P; Savettieri G; Licata G
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):152-7. PubMed ID: 17702553
[TBL] [Abstract][Full Text] [Related]
15. IL-6: an early marker for outcome in acute ischemic stroke.
Waje-Andreassen U; Kråkenes J; Ulvestad E; Thomassen L; Myhr KM; Aarseth J; Vedeler CA
Acta Neurol Scand; 2005 Jun; 111(6):360-5. PubMed ID: 15876336
[TBL] [Abstract][Full Text] [Related]
16. IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.
Cojocaru IM; Cojocaru M; Burcin C
Rom J Intern Med; 2006; 44(2):165-70. PubMed ID: 17236297
[TBL] [Abstract][Full Text] [Related]
17. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
[TBL] [Abstract][Full Text] [Related]
18. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke.
Welsh P; Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ
Cerebrovasc Dis; 2009; 27(3):247-53. PubMed ID: 19176958
[TBL] [Abstract][Full Text] [Related]
19. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke.
Nakase T; Yamazaki T; Ogura N; Suzuki A; Nagata K
J Neurol Sci; 2008 Aug; 271(1-2):104-9. PubMed ID: 18479710
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial progenitor cells in Chinese patients with acute stroke.
Zhou WJ; Zhu DL; Yang GY; Zhang Y; Wang HY; Ji KD; Lu YM; Gao PJ
Hypertens Res; 2009 Apr; 32(4):306-10. PubMed ID: 19262489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
